科研之友
微信
新浪微博
Facebook
分享链接
摘要
Nuclear medicine is increasingly affected by administrative regulations. Besides radiation safety measurements and controls, nuclear medicine faces increasing burdens from regulations on handling and preparation of radiopharmaceuticals. These result from general regulatory measurements on the, safety of pharmaceuticals. This article tries to demonstrate the puzzling interactions of regulatory bodies and institutions which lead to the regulatory framework, with focus on Germany.
- 出版日期2013
